From the American Academy of Ophthalmology

This retrospective, case-control study evaluated whether combining orbital radiotherapy with corticosteroids for thyroid eye disease lowered the risk of compressive optic neuropathy compared with corticosteroid therapy alone. Among 144 patients followed for an average of three years, the rate of compressive optic neuropathy was significantly lower (P < .0001) and improvement in ocular motility greater in patients receiving combined treatment. American Journal of Ophthalmology, June 2014

From the American Academy of Ophthalmology

From the American Academy of Ophthalmology

The U.S. Food and Drug Administration issued several policy documents on July 1 regarding compounded drug products for human use. This is part of the agency’s continuing effort to implement the Drug Quality and Security Act. Of primary concern to ophthalmology is final guidance for FDA policy on enforcement of section 503A for traditional compounding pharmacies.

From the American Academy of Ophthalmology